Vaginismus: Difference between revisions

(added pt treatment)
(added pharmacological therapy)
Line 120: Line 120:


===== Pharmacological therapy =====
===== Pharmacological therapy =====
There are 3 main types of pharmacological treatment for vaginismus
# '''Local anesthetics''' (e.g., lidocaine), Local anesthetics, such as lidocaine gel, is based on the rationale that muscle spasms in vaginismus are due to repeated pain experienced with vaginal penetration and by the use of a topical anesthetic there will be reduction in  the pain and thus the spasm will be treated.
# '''Muscle relaxants''' (e.g., nitroglycerin ointment and botulinum toxin)  A topical nitroglycerin ointment, treats the muscle spasm by relaxing the vaginal muscles, Botulinum toxin, a temporary muscle paralytic, has been recommended in the treatment of vaginismus with the aim of decreasing the hypertonicity of the pelvic floor muscles.  Patient who receives an injection of botulinum toxin are able to engage in ‘satisfactory intercourse'.
# '''Anxiolytic medication'''  use of anxiolytics, such as diazepam, in conjunction with psychotherapy based on the rationale that vaginismus is a psychosomatic condition resulting from past trauma and therefore anxiety reducing medications will resolve the symptoms.


===== Pelvic floor physiotherapy =====
===== Pelvic floor physiotherapy =====
It involves
It involves:-


* '''Counselling'''
* '''Counselling'''

Revision as of 18:03, 27 June 2022

Original Editor - Muskan Rastogi Top Contributors - Muskan Rastogi, Laura Ritchie, Kim Jackson and Lucinda hampton
This article or area is currently under construction and may only be partially complete. Please come back soon to see the finished work! (27/06/2022)

Definition[edit | edit source]

Vaginismus is a penetration disorder in which any form of vaginal penetration is painful or impossible. It has traditionally been referred to as an involuntary contraction of the pelvic floor muscles due to actual or anticipated pain associated with vaginal penetration. It causes women to feel pain, fear and anxiety with penetration attempts.[1]It is often associated with psychological problems, leading to poor sexual quality of life (SQOL).[2]

The debate around its definition[edit | edit source]

[3]

Anatomy[edit | edit source]

Prevalence and Incidence[edit | edit source]

It affects about 1-7% of the female population worldwide.[1] In primary care settings the same rate goes up to 30%[4]further drastically increasing to 42% in specialized clinics for female sexual disorders.[5][6]

Etiology[edit | edit source]

The etiological factors are- ( the given etiological factors are still not well established by the literature)

Organic pathologies[edit | edit source]
  • Congenital abnormalities
  • Local infections
  • Trauma associated with childbirth
  • Genital surgery or radiotherapy
  • Vaginal lesions and tumors [7][3]
Psychological factors[edit | edit source]
  • Sexual abuse
  • A negative attitude toward sexuality
  • Relationship difficulties
  • Fear of first-time sex (pain, bleeding, tearing, ripping, penis too large, vagina too small, sexually transmitted diseases, fear of pregnancy)[8]
  • Fear of gynecological examinations[8]
  • A maternal influence involving grandmothers, mothers, twins, and sisters-The influence is due to merely hearing about the difficulties faced by them and the patient may manifest it as a subsequent fear of penetration.[8]

Quality of life[edit | edit source]

This condition influences the quality of life, in the most serious form it can result in an unconsummated marriage, and sterility and thus further result in the couple leading a separate life. [1]It is correlated with poor sexual quality of life[2] and even the male partners may have important effects on the development, maintenance, and exacerbation of vaginismus ( in lifelong vaginismus -LLV).[9]Common psychological symptoms seen are depression, anxiety, low self-esteem, insecure attachment styles, histrionic/hysterical traits, and alexithymia.[3]

Symptoms[edit | edit source]

These symptoms are defined accordingly given by the Diagnostic and Statistical Manual of Mental Disorders (DSM, the American Psychiatric Association), fifth edition(DSM-5)[10]-

  • Difficulty having intercourse
  • Genito-pelvic pain
  • Fear of pain or vaginal penetration
  • Tension of the pelvic floor muscles.

Other symptoms-

  • Inability to use OR remove a tampon (often noted at a young age)
  • Complaints that attempted coitus is like “hitting a wall”
  • An inability to tolerate a gynaecological examination.

Pathophysiology/Mechanism[edit | edit source]

Types[edit | edit source]

  • Primary Vaginismus
  • Secondary Vaginismus

Grades[edit | edit source]

In 1978 Lamont[11] described the first four grades and a grade 5 was then later added by Pacik[8][12]. The Lamont grades were based on the patient's conduct during gynaecological examination and history taking whereas the Pacik grade 5 takes into account the severe fear and anxiety seen in the patient while performing the examination.

[8]
GRADES DESCRIPTION
Lamont grade 1 Patient is able to relax for pelvic examination
Lamont grade 2 Patient is unable to relax for pelvic examination
Lamont grade 3 Buttocks lift off the table. Early retreat
Lamont grade 4 Generalized retreat: buttocks lift up, thighs close, patient retreats
Pacik grade 5 Generalized retreat as in level 4 plus visceral reaction, which may result in any one or more of the following: palpitations, hyperventilation, sweating, severe trembling, uncontrollable shaking, screaming, hysteria, wanting to jump off the table, a feeling of becoming unconscious, nausea, vomiting, and even a desire to attack the doctor

Assessment[edit | edit source]

Checking the Degree of vaginal muscle hypertonus/spasm[12]

Degree of spasm Description
1-2 Minimal/mild degrees of vaginal hypertonus/spasm
3 Considerable vaginal hypertonus/spasm. Finger

penetration possible, but vaginal musculature is tight.

The patient is uncomfortable with the examination.

4 Presence of vaginal muscle spasm. Bulbocavernosus

seems like a tightly closed fist and digital penetration

is difficult to impossible without sedation.

Diagnosis[edit | edit source]

Differential diagnosis[edit | edit source]

Management[edit | edit source]

Non-surgical management[edit | edit source]

Behavioral sex therapy[edit | edit source]
CBT[edit | edit source]
Pharmacological therapy[edit | edit source]

There are 3 main types of pharmacological treatment for vaginismus

  1. Local anesthetics (e.g., lidocaine), Local anesthetics, such as lidocaine gel, is based on the rationale that muscle spasms in vaginismus are due to repeated pain experienced with vaginal penetration and by the use of a topical anesthetic there will be reduction in the pain and thus the spasm will be treated.
  2. Muscle relaxants (e.g., nitroglycerin ointment and botulinum toxin) A topical nitroglycerin ointment, treats the muscle spasm by relaxing the vaginal muscles, Botulinum toxin, a temporary muscle paralytic, has been recommended in the treatment of vaginismus with the aim of decreasing the hypertonicity of the pelvic floor muscles. Patient who receives an injection of botulinum toxin are able to engage in ‘satisfactory intercourse'.
  3. Anxiolytic medication use of anxiolytics, such as diazepam, in conjunction with psychotherapy based on the rationale that vaginismus is a psychosomatic condition resulting from past trauma and therefore anxiety reducing medications will resolve the symptoms.
Pelvic floor physiotherapy[edit | edit source]

It involves:-

  • Counselling
  • Breathing exercises
  • Relaxation exercises
  • Local tissue desensitization/Gradualized desensitization
  • Habituation
  • Vaginal dilators
  • Pelvic floor biofeedback
  • Manual therapy techniques


TREATMENT PROTOCOL [13]

  1. Counsel the patient- Educate the patient about the anatomy and physiology of the vulva, vagina, and pelvic floor muscles with the help of diagrams, pictures, and models. Explain the protective role of voluntary muscle contraction in response to pain or expected pain and emphasize the fact that the pain does not automatically implies that there is a tissue damage but it is rather helping to communicate us the threat or perceived danger. Explain the whole treatment procedure. Reassure the patient that the treatment can be discontinued whenever they want, therapist would not treat when they are anxious or fearful, the treatment will progress at patient's pace. Encourage the patient to invite their partner(if has one) to attend any or all of the treatment sessions and to involve the partner in home exercises regimen whenever possible.
  2. Ask patient to lie in supine position with knees bent and feet flat on the bed; head elevated on pillows so constant eye contact could be kept between the therapist (positioned at the foot of the treatment bed) and the patient. If the patient felt any pain or anxiety they need to articulate this by saying, “Stop.” The word “Stop” would indicate to the therapist to stop the movement or technique and stay still until the pain or anxiety reduced or ceased. Until the pain ceases take this opportunity to discuss the role of the nervous system and neuroplasticity in the treatment of vaginismus.
  3. Progression of the treatment session a. Being able to tolerate perineal pressure with the palm of the therapist’s hand b. Looking at her genitalia with a mirror. c. Tolerating the therapist resting one finger at the introitus. d. Tolerating the insertion of the finger into the vagina. e. Tolerating movement of the finger inside the vagina.
  4. This progression enables the usage of manual techniques to enhance proprioception and voluntary control of the pelvic floor muscles; techniques included stretches, myofascial and trigger point releases, and massage.
  5. Kegel exercises are to be given with resistance only and with a focus on relaxation rather than contraction. This implies that the patient can now carry out contract/relax exercises with a dilator vaginally inserted to assist in proprioception.
  6. Two finger insertion to inserting a tampon then to a series of three graduated dilators at last a speculum is used in gradual manner to increase patient's confidence.
  7. Teach the patient how to relax (“drop”) her pelvic floor muscles, ask them to practice this during the day if patient feels that the muscles are tense, and then to focus on dropping the pelvic floor during any insertion technique.
  8. Electromyographic biofeedback with a vaginal sensor should be used as a teaching tool whenever therapist feels its appropriate. With this technique, the patient can see the effect of contraction and relaxation of the pelvic floor muscles in a form of a graph whilst showing electrical muscle activity on the computer screen and thereby learning to recognize the sensation of a relaxed pelvic floor while receiving feedback from the electromyographic display.
  9. Transcutaneous electrical nerve stimulation, a low-intensity, biphasic electrical current delivered by a vaginal sensor, can be used to reduce pain through nociceptive inhibition in the dorsal horn of the spinal cord.
  10. Treatment techniques (e.g., stretches, dilator insertion) are assigned for home practice, either done by the patient alone or with her partner. Home exercises involves the patient inserting a finger, thumb, or dilator into the vagina, which is progressed to movement of fingers, then to massage of the vaginal walls and stretching of the opening of the vagina at 4, 6, and 8 o’clock. Massaging the vaginal walls gives patient a chance to palpate the muscular tension and to experience what contraction and relaxation of the pelvic floor muscles feels like, thereby improving proprioceptive awareness.
  11. Each steps mentioned above should be practiced until there is no pain or anxiety before moving on to the next step. Once the patient can tolerate insertion and movement of the larger dilator, preferably by her partner, the transition to intercourse should be encouraged. Also motivate the patient the use of stops as needed and with a focus on keeping the pelvic floor muscles relaxed at all times.

Surgical management[edit | edit source]

Removal of hymenal remnants[edit | edit source]

References[edit | edit source]

  1. 1.0 1.1 1.2 Laskowska A, Gronowski P. Vaginismus: An overview. The Journal of Sexual Medicine. 2022 May 1;19(5):S228-9.
  2. 2.0 2.1 Psychological predictors of sexual quality of life among women with vaginismus, Velayati A, Jahanian Sadatmahalleh S, Ziaei S, Kazemnejad A. Psychological predictors of sexual quality of life among Iranian women with vaginismus: A cross-sectional study. International Journal of Sexual Health. 2022 Jan 2;34(1):81-9.
  3. 3.0 3.1 3.2 Maseroli E, Scavello I, Rastrelli G, Limoncin E, Cipriani S, Corona G, Fambrini M, Magini A, Jannini EA, Maggi M, Vignozzi L. Outcome of medical and psychosexual interventions for vaginismus: a systematic review and meta-analysis. The journal of sexual medicine. 2018 Dec 1;15(12):1752-64.
  4. Read S, King M, Watson J. Sexual dysfunction in primary medical care: prevalence, characteristics and detection by the general practitioner. Journal of Public Health. 1997 Dec 1;19(4):387-91.
  5. Oniz A, Keskinoglu P, Bezircioglu I. The prevalence and causes of sexual problems among premenopausal Turkish women. The journal of sexual medicine. 2007 Nov 1;4(6):1575-81.
  6. Nusbaum MR, Gamble G, Skinner B, Heiman J. The high prevalence of sexual concerns among women seeking routine gynecological care. Journal of Family practice. 2000 Mar 1;49(3):229-.
  7. Lahaie MA, Boyer SC, Amsel R, Khalifé S, Binik YM. Vaginismus: a review of the literature on the classification/diagnosis, etiology and treatment. Women’s Health. 2010 Sep;6(5):705-19.
  8. 8.0 8.1 8.2 8.3 8.4 Pacik PT. Understanding and treating vaginismus: a multimodal approach. International urogynecology journal. 2014 Dec;25(12):1613-20.
  9. Turan Ş, Sağlam NG, Bakay H, Gökler ME. Levels of depression and anxiety, sexual functions, and affective temperaments in women with lifelong vaginismus and their male partners. The Journal of Sexual Medicine. 2020 Dec 1;17(12):2434-45.
  10. American Psychiatric Association DS, American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM-5. Washington, DC: American psychiatric association; 2013 May.
  11. Lamont JA. Vaginismus. American Journal of Obstetrics and Gynecology. 1978 Jul 15;131(6):632-6.
  12. 12.0 12.1 Pacik PT, Babb CR, Polio A, Nelson CE, Goekeler CE, Holmes LN. Case series: redefining severe grade 5 vaginismus. Sexual Medicine. 2019 Dec 1;7(4):489-97.
  13. Reissing ED, Armstrong HL, Allen C. Pelvic floor physical therapy for lifelong vaginismus: a retrospective chart review and interview study. Journal of sex & marital therapy. 2013 Jul 1;39(4):306-20.